The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
ClarVista Medical says it pulled in $14 million in a Series B round for its new intraocular lens replacement used after cataract surgery.
California startup ClarVista Medical said it raised a $14 million Series B round slated for development of its adjustable post-cataract surgery intraocular lens replacement. Cycad Group and Windham Venture Partners co-led the round, along with existing investor New Enterprise Associates, ClarVista said.
Analyst: Boston Scientific and St. Jude Medical stand out at the annual meeting of the Heart Rhythm Society in Boston.
The outlook for ablation and cardiac rhythm management technologies is looking up, according to Leerink Partners analyst Danielle Antalffy, writing after reviewing the latest offerings from medical device companies at the annual Heart Rhythm Society meeting in Boston recently.
Registrar Corp's U.S. FDA News blog provides regulatory updates for FDA regulated industries. Registrar Corp helps medical device establishments comply with FDA regulations, such as registration, listing, UDI and GUDID requirements, 510(k) requirements, and more.
By David Lennarz, Vice President and Co-Founder of Registrar Corp
Life science venture investing and incubation firm PureTech Health looks to raise $160 million in an initial public offering on the London Stock Exchange.
(Reuters) — Boston-based PureTech Health plans to raise $160 million in a London listing, filling its coffers to fund product development and delivering a vote of confidence on the British life sciences sector.
The move by the U.S. health technology firm follows a similar decision by California-based drug discovery group Verseon to raise $100 million in London earlier this month.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.